Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

Aldosterone Recumbent

Endocrine & Reproductive

ALDOAldosterone, supinePlasma aldosterone (recumbent)

Review status

Currently under review

Pending specialist review and validation.

What it shows

This test measures aldosterone, a hormone made by your adrenal glands that helps control salt and water balance. Aldosterone signals your kidneys to retain sodium and excrete potassium, which affects blood volume and blood pressure.

Recumbent means the sample is collected after you have been lying down quietly. Posture changes aldosterone levels, so measuring it while you are recumbent helps standardize the conditions. The test is usually done on a blood sample and is often interpreted together with a renin test to understand how the hormone system that regulates blood pressure is functioning.

Why it matters

Your clinician may order this test if you have high blood pressure that is hard to control, low potassium, or symptoms that suggest an imbalance in salt and water regulation. It helps evaluate conditions such as primary aldosteronism, where too much aldosterone is produced, and can also contribute to the assessment of adrenal insufficiency when aldosterone may be inappropriately low.

Results guide further workup and treatment choices. Knowing your aldosterone level under recumbent conditions can improve accuracy when comparing with renin and when deciding whether additional confirmatory testing, medication adjustments, or imaging is needed.

Understanding your results

Your aldosterone level is interpreted in the context of your symptoms, blood pressure, potassium level, renin level, and medications. A higher-than-expected aldosterone can point to overproduction, while a lower-than-expected level can occur with adrenal underactivity or certain medicines. Because posture, salt intake, and timing can influence the result, standardized collection and careful review are important.

If your result is outside the expected range, your clinician may repeat testing under controlled conditions, review medicines that could interfere, or order follow-up tests such as a renin level, suppression or stimulation tests, or imaging. Do not start or stop medicines on your own; changes should be guided by your care team.

Reference ranges

83444 pmol/L
All sexes
0 days – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact Aldosterone Recumbent

  • Posture and Rest

    Aldosterone changes with posture. For the recumbent test you should lie quietly for a set period before the blood draw. Standing, walking, or sitting before the sample can raise values and affect interpretation.

  • Time of Day

    Aldosterone has a daily rhythm. Early morning collection under standardized conditions is often preferred. Testing at different times can make comparisons difficult.

  • Salt and Fluid Intake

    High sodium intake can lower aldosterone, while low sodium or dehydration can increase it. Follow your clinician’s instructions on diet and fluids before testing.

  • Medications

    Diuretics, ACE inhibitors, ARBs, beta blockers, mineralocorticoid receptor blockers, oral contraceptives, and licorice products can alter aldosterone or renin. Ask your clinician which medicines to continue or hold before the test.

  • Illness and Stress

    Acute illness, fever, pain, or significant stress can change hormone levels. If you are unwell, your clinician may recommend delaying the test until you recover.

  • Pregnancy and Hormonal States

    Pregnancy and some hormonal therapies can increase aldosterone and renin. Your clinician will interpret results with these factors in mind.

2026

References

  1. McGill University Health Centre. (2012, September 15). Aldosterone Recumbent (Task CD 315846). Laboratory reference ranges.
  2. Funder, J. W., Carey, R. M., Mantero, F., Murad, M. H., Reincke, M., Shibata, H., Stowasser, M., & Young, W. F., Jr. (2016). The management of primary aldosteronism: Case detection, diagnosis, and treatment: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 101(5), 1889-1916. External link